Targeting polyketide synthase 13 for the treatment of tuberculosis
- 1 August 2023
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 259, 115702
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Identification of New Drug Targets and Resistance Mechanisms in Mycobacterium tuberculosisPLOS ONE, 2013
- In Vitro Combination Studies of Benzothiazinone Lead Compound BTZ043 against Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2012
- Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitorsProceedings of the National Academy of Sciences, 2012
- New insights into the formation of fungal aromatic polyketidesNature Reviews Microbiology, 2010
- Antituberculosis activity of the molecular libraries screening center network libraryTuberculosis, 2009
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37RvTuberculosis, 2009
- The Pks13/FadD32 Crosstalk for the Biosynthesis of Mycolic Acids in Mycobacterium tuberculosisJournal of Biological Chemistry, 2009
- Treatment of isoniazid-resistant pulmonary tuberculosisBMC Infectious Diseases, 2008
- A Mechanism-Based Aryl Carrier Protein/Thiolation Domain Affinity ProbeJournal of the American Chemical Society, 2007
- AccD6, a Member of the Fas II Locus, Is a Functional Carboxyltransferase Subunit of the Acyl-Coenzyme A Carboxylase in Mycobacterium tuberculosisJournal of Bacteriology, 2007